Results 191 to 200 of about 216,217 (284)

Effect of tau burden and Lewy pathology on neuropsychiatric symptoms in Aβ-positive individuals. [PDF]

Alzheimers Dement
Kang S, Ye BS, Yun M, Lee YG, Alzheimer's Disease Neuroimaging Initiative.   +4 more
europepmc   +1 more source

Discrepant Views of Apathy in Patients and Caregivers: the Role of Cognitive Deficits in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Apathy is a common early symptom of Parkinson's disease (PD), often co‐occurring with cognitive decline and associated with fronto‐striatal and mesocortico‐limbic dysfunctions. Discrepancies between self‐ and caregiver‐reported apathy have been preliminarily associated with cognitive impairments affecting patients’ awareness and ...
Giulia Funghi, Francesca Fabris, Claudia Meli, Chiara Speranza, Giuseppe Rabini, Giorgio Giulio Fumagalli, Francesca Zappini, Selene Schintu, Raffaella Di Giacopo, Stefano Tambalo, Luca Turella, Jorge Jovicich, Costanza Papagno, Alessandra Dodich   +13 more
wiley   +1 more source

Investigating Sleep Concerns in Cervical Dystonia

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Heterogenous, small cohorts, and co‐occurrence of pain and psychiatric burden complicate understanding of sleep in dystonia. Objective To investigate sleep concerns in cervical dystonia (CD). Methods Longitudinal data from CD‐PROBE on subjects who were toxin‐naïve, new to practice, or without injections for at least 16 weeks were ...
Abhimanyu Mahajan, David Andrés González, Cynthia Comella   +2 more
wiley   +1 more source

Association between anosognosia and neuropsychiatric symptoms in Alzheimer's disease dementia patients. [PDF]

Sci Rep
Elnemais Fawzy M, Wang S, Palmer P, Gatchel J, Marshall GA, Gagliardi G, Vannini P, Alzheimer’s Disease Neuroimaging Initiative.   +7 more
europepmc   +1 more source

Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Clinical outcome assessments (COAs) are essential for evaluating symptom severity, treatment response, and disease progression in Parkinson's disease (PD). As clinical knowledge evolves, it is necessary to revisit the recommendation status on the COAs to ensure their continued relevance and validity. Objectives To provide an updated
Evita Papathoma, Panagiota Tsitsi, Nirosen Vijiaratnam, Camila Aquino, Stephen R. Duma, Norbert Kovacs, Kigocha Lameck Okeng'o, Aparna Wagle Shukla, Roongroj Bhidayasiri, Tiago A. Mestre, Alvaro Sanchez Ferro, Alberto J. Espay, Michelle H.S. Tosin, Matej Skorvanek, Ioanna Markaki   +14 more
wiley   +1 more source

Personalized AZithromycin/metronidAZole + dietary therapy in pediatric Crohn disease: Results of a pilot study

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Charlotte M. Verburgt, Nikki van der Kruk, Katherine A. Dunn, PAZAZ‐study investigators, Charlotte M. Verburgt, Nikki van der Kruk, Katherine A. Dunn, Joseph P. Bielawski, Anthony R. Otley, Tim de Meij, Francisco Sylvester, Andre M. Comeau, Morgan G. I. Langille, Wouter J de Jonge, Johan E. Van Limbergen, Johan E. Van Limbergen   +15 more
wiley   +1 more source

Motor and Cognitive Outcome After Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease Harboring GBA1 Variant

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Deep brain stimulation (DBS) is effective for Parkinson's disease (PD); however, its efficacy varies with genetic background, such as the GBA1 variant—the causative gene of Gaucher disease—associated with increased PD risk and cognitive decline after subthalamic nucleus (STN)‐DBS.
Hikaru Kamo, Genko Oyama, Mai Shimizu, Haruka Takeshige‐Amano, Takashi Ogawa, Wataru Sako, Noriko Nishikawa, Taku Hatano, Yuanzhe Li, Hiroyo Yoshino, Manabu Funayama, Masanobu Ito, Hirokazu Iwamuro, Atsushi Umemura, Nobutaka Hattori   +14 more
wiley   +1 more source

Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Movement disorders have recently emerged as important neurologic manifestations of the 22q11.2 microdeletion that affects nearly one in every 2000 live births. Objective We aimed to map the existing evidence regarding the spectrum, diagnosis and treatment, and etiopathogenesis of movement disorders associated with 22q11.2 ...
Nikolai Gil D. Reyes, Daniel G. Di Luca, Connie Marras, Erik Boot, Ryan K.C. Yuen, Anthony E. Lang, Anne S. Bassett   +6 more
wiley   +1 more source

Neuropsychiatric symptoms in Mild Cognitive Impairment

Annals of General Psychiatry, 2010
Ozbabalık Demet, Kilicoglu Alev, Algin Demet   +2 more
doaj   +1 more source